Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs. Marcaine TAP Block for Hernia Repairs
NCT05177991Phase 1Active, not recruiting
- Start
- Mar 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms). Primary endpoint: Subjective Pain Scores using Visual Analog Scale at 1 week. Started Mar 2022; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05177991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177991.